share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/07/30 21:05

Moomoo AI 已提取核心訊息

Agape ATP Corporation has entered into two significant collaboration agreements on July 24, 2024, marking its strategic expansion into new healthcare segments. The company partnered with Sweet Home Senior Living Care Centre to venture into senior and elderly care solutions, while simultaneously establishing a collaboration with Cedar Wellness to enter the pain management market.As part of the Cedar Agreement, Cedar's founder and management team will join Cedar ATPC Sdn. Bhd., a subsidiary of Agape ATP, as executive officers to lead the pain management solution business. These partnerships represent a significant diversification of Agape ATP's healthcare portfolio and service offerings.
Agape ATP Corporation has entered into two significant collaboration agreements on July 24, 2024, marking its strategic expansion into new healthcare segments. The company partnered with Sweet Home Senior Living Care Centre to venture into senior and elderly care solutions, while simultaneously establishing a collaboration with Cedar Wellness to enter the pain management market.As part of the Cedar Agreement, Cedar's founder and management team will join Cedar ATPC Sdn. Bhd., a subsidiary of Agape ATP, as executive officers to lead the pain management solution business. These partnerships represent a significant diversification of Agape ATP's healthcare portfolio and service offerings.
Agape ATP公司在2024年7月24日簽署了兩項重要的合作協議,標誌着其在新的醫療保健領域的戰略擴展。該公司與Sweet Home Senior Living Care Centre合作,進入老年護理解決方案,同時與Cedar Wellness建立合作,進軍疼痛管理市場。根據Cedar協議,Cedar的創始人和管理團隊將加入Agape ATP的子公司Cedar ATPC Sdn. Bhd.,擔任執行官,領導疼痛管理解決方案業務。這些合作標誌着Agape ATP醫療保健投資組合和服務產品的重大多樣化。
Agape ATP公司在2024年7月24日簽署了兩項重要的合作協議,標誌着其在新的醫療保健領域的戰略擴展。該公司與Sweet Home Senior Living Care Centre合作,進入老年護理解決方案,同時與Cedar Wellness建立合作,進軍疼痛管理市場。根據Cedar協議,Cedar的創始人和管理團隊將加入Agape ATP的子公司Cedar ATPC Sdn. Bhd.,擔任執行官,領導疼痛管理解決方案業務。這些合作標誌着Agape ATP醫療保健投資組合和服務產品的重大多樣化。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息